Stage I Prostate Cancer Completed Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Prostate cancer stage I / Carcinoma of the prostate stage I / Prostatic cancer stage I

IndicationStatusPhase
DBCOND0028877 (Stage I Prostate Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01656304Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone TherapyTreatment